Alzheimer's disease (AD) causes gradual cognitive decline and dementia.
Until recently, the definitive diagnosis of AD was based on autopsy assessments of brain amyloid-β plaques and tau neurofibrillary tangles, the defining biological features of AD. Biomarkers of amyloid-β and tau are vital for measuring AD pathology in living people and for differentiating between different neurodegenerative diseases.
With the latest progress in AD research, accurate in-vivo diagnosis of AD is becoming increasingly crucial: before starting treatment with anti-amyloid therapies, it's essential to determine if amyloid positivity is present. This article...
Parkinson's disease review on symptoms, nursing care, treatment, and pathophysiology NCLEX review.
Parkinson's disease is a neuro disease that affects movement. What is happening in...
Alzheimer's disease is a progressive neurological disorder that affects memory, thinking skills, and eventually the ability to carry out the simplest tasks. It is...
Salmon is a powerhouse of nutrients that can play a significant role in preventing dementia and Alzheimer’s disease. Rich in omega-3 fatty acids, particularly...
For the first time, a study suggests Alzheimer's may be preventable if treatment begins before symptoms appear. Dr. Jon LaPook spoke with Dr. Randall...